What is Novasight?
NovaSight specializes in transforming pediatric vision care with its innovative eye tracking and data analytics solutions. The company's flagship products, CureSight and TrackSight, are designed for remote digital treatment of amblyopia and myopia management, making vision care more engaging and accessible for children. By enhancing the accuracy and efficiency of vision assessments, NovaSight provides healthcare professionals with critical insights derived from advanced technology, aiming to improve vision health for children globally.
How much funding has Novasight raised?
Novasight has raised a total of $8M across 1 funding round:
Series A
$8M
Series A (2020): $8M with participation from Rimonci Capital
Key Investors in Novasight
Rimonci Capital
Rimonci Capital is an investment firm that participated in Novasight's Series A funding round. Their involvement suggests a focus on companies with strong technological innovation and significant market potential, particularly within the healthcare technology sector.
What's next for Novasight?
With a major enterprise-level funding context and a recent strategic investment, Novasight is poised for significant expansion. This capital infusion is expected to accelerate product development, enhance market penetration, and further solidify its position in the pediatric vision care sector. The company's focus on remote digital treatments for conditions like amblyopia and myopia suggests a strategic push towards telehealth and data-driven healthcare solutions, positioning Novasight as a key innovator in the digital health landscape.
See full Novasight company page
